Source: Eur Respir J, 50 (2) 1700148; 10.1183/13993003.00148-2017
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brigitte Benard, Valérie Bastien, Benjamin Vinet, Roger Yang, Maja Krajinovic, Francine M. Ducharme. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice. Eur Respir J, 50 (2) 1700148; 10.1183/13993003.00148-2017

Member's Comments

No comment yet.

Related content which might interest you: Neuropsychiatric adverse effects of montelukast in children Source: Eur Respir J, 50 (2) 1701020; 10.1183/13993003.01020-2017 Year: 2017 Montelukast: neuropsychiatric adverse drug reactions in Tunisian asthmatic children Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure Year: 2018 Adherence to inhaled controller therapy and local adverse events in children with asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Management of adverse drug events in TB therapy Source: Eur Respir Mon 2012; 58: 167-193 Year: 2012 Possible neuropsychic adverse reactions with montelukast in childhood asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001 Safety of formoterol in children and adolescents: experience from asthma clinical trials Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Adverse anti-tuberculosis drug events and their management Source: Eur Respir Monogr 2018; 82: 205-227 Year: 2018 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 The effect of inhaled corticosteroids on symptoms in pre-school children with asthma-like symptoms in general practice: the ASTERISK study Source: Eur Respir J 2004; 24: Suppl. 48, 165s Year: 2004 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 566-567 Year: 2015 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2014; 44: 332-340 Year: 2014 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 565-566 Year: 2015 No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Respiratory adverse effects in oncology nurses exposed to antineplastic drugs Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies Year: 2015 The Anglo-French real-life experience of maintenance OCS use in omalizumab-treated patients with severe persistent allergic asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Italian real-life experience of omalizumab Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data Source: International Congress 2018 – Tests and trends in asthma Year: 2018